@FierceBiotech: ICYMI: Merck's new R&D chief Perlmutter begins major shakeup. Report | Follow @FierceBiotech
@JohnCFierce: J&J snags another promising prostate cancer drug in $1B Aragon buyout. News | Follow @JohnCFierce
@RyanMFierce: 2013 Fierce 15 survey: Tell us who you think will be the next Aragon or privately held biotech to get acquired. Submit your nominations now | Follow @RyanMFierce
@EmilyMFierce: Inovio says H7N9 bird flu vaccine effective in mice. Article | Follow @EmilyMFierce
> AstraZeneca ($AZN) has struck a deal to partner with NGM Biopharmaceuticals on a discovery deal related to NGM's enteroendocrine cell (EEC) program for diabetes and obesity drugs. Release
> Gilead Sciences ($GILD) says that interim results from a single-arm, open-label Phase II study of idelalisib in patients with indolent non-Hodgkin's lymphoma demonstrated an overall response rate of 53.6 percent, with a median duration of response at this interim analysis of 11.9 months. Release
> MannKind's long-awaited Phase III follow-up study for Afrezza has been completed, paving the way to an announcement on the data later this summer. Release
@FierceMedDev: Amaranth's dissolving cardiac stent drives $25M fundraising round. Story | Follow @FierceMedDev
@DamianFierce: ADC superstar Ambrx is reaching out to WuXi to develop a cancer drug of its own. From FierceCRO | Follow @DamianFierce
@MarkHFierce: Curious to hear from readers--what device and diagnostics companies do you see as major M&A targets through the rest of 2013? LinkedIn discussion | Follow @MarkHFierce
@MichaelGFierce: Drug-carrying 'nanovolcanoes' make precise delivery structures. From FierceDrugDelivery | Follow @MichaelGFierce
> German court upholds Medtronic's CoreValve heart pump patent. Article
> More diagnostics companies pounce in wake of SCOTUS gene decision. Item
> J&J/Mentor wins U.S. sign-off for silicone breast implant, with conditions. More
Pharma News
@FiercePharma: Supremes rule in pay-for-delay case: 5-3 vote slaps down AbbVie/Actavis plea for protection from lawsuits over patent settlements. | Follow @FiercePharma
@EricPFierce: India's Wockhardt in serious hurt between FDA import alert and India's decision to pull pain drug. Story | Follow @EricPFierce
> Supreme Court slaps pharma aside in pay-for-delay ruling. News
> With $135M rights deal, Questcor locks up rival to its pricey Acthar drug. Story
> Novo's quick-selling Victoza threatened by Lilly diabetes hopeful. More
CRO News
> Synexus wins Pfizer's favor for South African trials. More
> Ash Stevens signs on for Ariad's blockbuster contender. Item
> Ambrx taps WuXi for HER2-targeting cancer drug. Report
> Almac adding 229 jobs in Irish CMO expansion. Article
> Catalent puts $35M into CMO plant. Story
> MPI teams up with imaging outfits to woo drug developers. News
Biotech IT News
> Berkeley professor: Genomic data leaks seem inevitable. More
> Cancer Research UK mulls multiple video game options. Report
> 23andMe seeks consumer boost in long-range data strategy. Story
> FDA joins chorus of concern about cybersecurity threats. More
> Firm tries startup's tech tricks for clinical trial recruitment. Article
And Finally… A new study shows that men who suffer from restless leg syndrome also face a significantly higher risk of death. Story